Learn about MSK’s Healthy Living, a lifestyle program for people with breast cancer, where diet, nutrition, exercise and integrative medicine come together to improve quality of life.

Discover the joys of crafting your very own DIY terrarium and transform your space into a green oasis! Whether this is your first time or you are a crafty botanical enthusiasts, this virtual workshop ...

Learn about a new approach to helping reduce the risk of stomach and esophageal cancer coming back after surgery, thanks to a clinical trial with immunotherapy led by researchers at MSK.

Learn about a clinical trial that used immunotherapy alone to treat people with several different types of cancer, meaning they did not need to undergo surgery, radiation or chemotherapy.

For the first time, a targeted drug is showing promise at treating non-small cell lung cancer caused by a mutation called KRAS-G12D.

MSK physician-scientists Dr. Viviane Tabar and Dr. Lorenz Studer have developed a treatment for Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them ...

MSK is proud to announce that four Sloan Kettering Institute (SKI) researchers have been named 2025 Marie-Josée Kravis Women in Science Endeavor (Kravis WiSE) fellowship grant recipients.

Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN) and Memorial Sloan Kettering Cancer Center (MSK), a leading global cancer center, today announced a collaboration harnessing the ...

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood ...

Learn about some of the most important advances in cancer treatment and clinical trials at MSK in 2024.

Today researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from the first ever clinical trial to show that a high fiber plant based dietary intervention may delay progression ...

A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for treating patients in different age groups.